新型机器人电磁导航支气管镜平台集成TiLT技术首次人体研究:FRONTIER研究
FRONTIER研究首次在人体中评估集成工具入病灶断层合成(TiLT)技术的新型机器人电磁导航支气管镜系统(Galaxy System)用于周围型肺结节采样。目标到达率100%,活检工具均在目标病灶内可视化,确诊率89.5%(严格)至94.7%(中间),安全性可接受。
要点
- 新型机器人电磁导航联合TiLT技术对周围型肺结节目标到达率100%,活检工具均在病灶内可视化。
- 确诊率严格标准89.5%、中间标准94.7%,17个结节获得明确诊断,其中13个为恶性。
- 并发症包括需观察的气胸和需过夜胸腔引流的气胸各1例,另有1例术后重症肺炎。
核心结论
- 第二代机器人支气管镜联合电磁导航与集成数字断层合成技术可行,安全性可接受,对小型周围型肺结节诊断率较高。
研究设计与样本
- 首次人体临床试验,纳入中度风险周围型肺结节患者,使用Galaxy System(Noah Medical)行机器人电磁导航联合TiLT辅助病灶引导。
- 非特异性结果随访至明确诊断或6个月复查影像学稳定。
主要发现
- 目标到达率100%,活检工具在所有病例中均于目标病灶内可视化。
- 17个结节获得确诊,其中13个为恶性;1例患者影像学监测确认真非恶性结果。
- 确诊率严格标准89.5%,中间标准94.7%。
- 并发症包括1例仅需观察的气胸、1例需过夜胸腔引流的气胸和1例术后重症肺炎。
临床怎么用
- 对于周围型肺结节,该新型机器人电磁导航联合TiLT平台可实现高目标到达率和病灶内工具可视化,诊断率较高且安全性可接受。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: As the presentation of pulmonary nodules increases, the importance of a safe and accurate method of sampling peripheral pulmonary nodules is highlighted. First-generation robotic bronchoscopy has successfully assisted navigation and improved peripheral reach during bronchoscopy. Integrating tool-in-lesion tomosynthesis (TiLT) may further improve yield. METHODS: We performed a first-in-human clinical trial of a new robotic electromagnetic navigation bronchoscopy system with integrated digital tomosynthesis technology (Galaxy System, Noah Medical). Patients with moderate-risk peripheral pulmonary nodules were enrolled in the study. Robotic bronchoscopy was performed using electromagnetic navigation with TiLT-assisted lesion guidance. Non-specific results were followed up until either a clear diagnosis was achieved or repeat radiology at 6 months demonstrated stability. RESULTS: Eighteen patients (19 nodules) were enrolled. The average lesion size was 20 mm, and the average distance from the pleura was 11.6 mm. The target was successfully reached in 100% of nodules, and the biopsy tool was visualized inside the target lesion in all cases. A confirmed specific diagnosis was achieved in 17 nodules, 13 of which were malignant. In one patient, radiological monitoring confirmed a true non-malignant result. This translates to a yield of 89.5% (strict) to 94.7% (intermediate). Complications included one pneumothorax requiring observation only and another requiring an overnight chest drain. There was one case of severe pneumonia following the procedure. CONCLUSION: In this first-in-human study, second-generation robotic bronchoscopy using electromagnetic navigation combined with integrated digital tomosynthesis was feasible with an acceptable safety profile and demonstrated a high diagnostic yield for small peripheral lung nodules.
引用
- Saghaie T, Williamson JP, Phillips M, et al. First-in-human use of a new robotic electromagnetic navigation bronchoscopic platform with integrated Tool-in-Lesion Tomosynthesis (TiLT) technology for peripheral pulmonary lesions: The FRONTIER study. Respirology. 2024. PMID: 38923084. doi:10.1111/resp.14778
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。